Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Euro area: Indirect inflation effects still pending – Societe Generale

Euro area: Indirect inflation effects still pending – Societe Generale

FXStreetFXStreet2026/07/03 14:09
By:FXStreet

Societe Generale economists Sam Cartwright, Michel Martinez and Jorge Garayo note that Euro area inflation has not yet shown indirect effects from the energy shock in food or goods prices. They expect lower Brent to push headline inflation to 2.55% yoy in July and to trim around 0.5pp from 2026 inflation, but still see delayed pass-through lifting core and food inflation later in 2026.

Energy shock pass-through still delayed

"Euro area inflation has yet to show any signs of indirect inflationary effects from the energy shock. In the near term, euro area inflation is likely to benefit further from the fall in Brent, possibly pushing headline inflation to 2.55% yoy in July. However, the pass-through from higher upstream energy commodity prices to consumer prices takes time."

"Therefore, we still believe that indirect effects will push up core inflation and, alongside weather-related effects, food inflation later in the year, although these effects are likely to be weaker than previously estimated."

"So far, euro area inflation has yet to show any meaningful indirect inflationary effects from the energy shock in either food or goods inflation, the two sectors where these indirect effects are likely to be most prominent."

"However, given that food and core inflation tend to peak around 16 months after an energy shock, a large share of the inflationary effects from the shock and related supply disruptions have yet to pass through."

"More generally, the fall in energy prices has lowered our headline inflation forecast by around 0.5pp throughout 2026, with the peak in headline inflation now at 3% in late-2026, conditional on the MoU holding."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales